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Endometriosis is a chronic and debilitating condition affecting ∼10% of women.
Endometriosis is characterized by infertility and chronic pelvic pain, yet treatment options
remain limited. In many respects this is related to an underlying lack of knowledge of
the etiology and mechanisms contributing to endometriosis-induced pain. Whilst many
studies focus on retrograde menstruation, and the formation and development of lesions
in the pathogenesis of endometriosis, the mechanisms underlying the associated pain
remain poorly described. Here we review the recent clinical and experimental evidence of
the mechanisms contributing to chronic pain in endometriosis. This includes the roles of
inflammation, neurogenic inflammation, neuroangiogenesis, peripheral sensitization and
central sensitization. As endometriosis patients are also known to have co-morbidities
such as irritable bowel syndrome and overactive bladder syndrome, we highlight how
common nerve pathways innervating the colon, bladder and female reproductive tract
can contribute to co-morbidity via cross-organ sensitization.
Keywords: chronic pelvic pain, sensory afferents, uterus, vagina, inflammation, neuroangiogenesis, peripheral
sensitization, hyperalgesia
INTRODUCTION
Endometriosis is a chronic and debilitating condition characterized by chronic pelvic pain (CPP)
and infertility. Endometriosis has a large clinical burden, affecting approximately 1 in 10 women
globally (Simoens et al., 2007; Adamson et al., 2010; Nnoaham et al., 2011). As such, endometriosis
is associated with significant societal and economic burden that costs the US economy $22 billion
annually in lost productivity and direct healthcare costs (Simoens et al., 2007; Adamson et al., 2010;
Nnoaham et al., 2011). Despite this burden, the etiology and pathogenesis of endometriosis remains
poorly defined, whilst efficacious therapeutic interventions remain limited.
Endometriosis is diagnosed surgically by the presence of endometrial lesions outside of the
uterus. However, surgical intervention and diagnosis are usually preceded by bouts of chronic
abdominal pain and/or CPP, leading patients to present to their consulting physician. More than
60% of women diagnosed with endometriosis report CPP, with endometriosis patients 13 times
more likely to experience abdominal pain than healthy subjects (Ballard et al., 2008). Despite
this disease homogeneity, the mechanisms by which endometriosis induces a chronic pain state
remain poorly understood (Ballard et al., 2008). Surgical removal of endometrial lesions can be
successful in alleviating pain in endometriosis patients, supporting a role of these lesions in chronic
pain. However, disparity exists in the correlation between pain severity and lesion score (Porpora
et al., 1999). Moreover, chronic pain frequently returns in patients within 12 months of lesion
removal, even in the absence of lesion regeneration (Abbott et al., 2004; Shakiba et al., 2008).
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As such, there is a clear disconnect between the traditional
theory that endometriosis associated pain is solely dependent on
lesions, and the reality experienced by endometriosis patients
throughout the world. This disconnect is further highlighted
by the observation that endometriosis patients frequently suffer
from a number of clinical comorbidities. Endometriosis is
commonly co-diagnosed with bladder and colon disorders that
are characterized by sensory dysfunction, such as overactive
bladder syndrome (OAB), and irritable bowel syndrome (IBS)
(Surrey et al., 2018). These comorbidities are suggestive of a
more complex pathophysiology for endometriosis induced pain
that cannot be explained by endometrial lesions alone. Growing
evidence now indicates that a chronic remodeling of the nervous
system occurs in shared sensory neural pathways to induce a state
of protracted peripheral and central sensitization and chronic
pain in endometriosis patients.
In this review, we summarize the most recent clinical
and preclinical research to highlight advances in determining
the mechanisms underlying the development of endometriosis
associated CPP and chronic abdominal pain. In particular, we
highlight the mechanisms occurring in the periphery.
Pathogenesis
As an estrogen dependent disorder, endometriosis
predominantly effects women of reproductive years aged
15–50 (Giudice and Kao, 2004). Endometriosis is a chronic
inflammatory condition, characterized by the migration of
uterine endometrial cells into the pelvic cavity, where they form
lesions on multiple sites across multiple organs. Retrograde
menstruation is the generally accepted mechanism underlying
the pathogenesis of endometriosis (Sampson, 1927; Giudice
and Kao, 2004). This mechanism was originally proposed
in 1927, whereby endometrial fragments migrate from the
fallopian tubes into the peritoneal cavity during menstruation
(Figure 1). However, retrograde menstruation naturally
occurs in 90% of women, but only 10% of women develop
endometriosis (Halme et al., 1984b). More recent data show the
prevalence of retrograde menstruation is no different in women
with or without endometriosis, suggesting a more complex
etiology (Kruitwagen et al., 1991; O et al., 2017). Patients
with endometriosis typically have more frequent and higher
volumes of menstrual flow, shorter menstrual cycle intervals and
increased endometrial fragments in the peritoneal cavity (Liu and
Hitchcock, 1986; Tal et al., 2019). Once the endometrial debris
becomes ectopic, adhesion needs to occur in order to initiate
the development of lesions and the induction of endometriosis.
While the mechanisms underlying this process remain unclear,
it is considered that immune dysfunction and the subsequent
inability to effectively clear these fragments enables endometrial
lesions to form in the peritoneal cavity (Giudice and Kao, 2004).
Normal menstruation requires the initiation of an innate
immune response to provide cyclical breakdown and clearing
of endometrial cells from the uterus in a highly regulated
process (Critchley et al., 2001). Similarly, in women who
don’t develop endometriosis, ectopic endometrial debris is
cleared from the peritoneum by an innate immune response
characterized by increased local neutrophils, macrophages,
natural killer (NK) cells and dendritic cells (O et al., 2017; Symons
et al., 2018). Dysregulation in this innate immune response in
response to ectopic endometrial tissue has been implicated in
endometriosis pathophysiology. Numerous studies have shown
increased peritoneal macrophages in response to the infiltration
of circulating monocytes in the peritoneal cavity (Halme et al.,
1984a; Amaral et al., 2006; Banu et al., 2008), which facilitate
the growth of endometrium-like tissue (Oosterlynck et al., 1992;
Dmowski et al., 1998; Chuang et al., 2010). In women without
endometriosis, tight regulation and control of immune cells clears
the way for the next menstrual cycle. However, in women with
endometriosis the chronic inflammatory milieu has been linked
to the generation of pain (Laux-Biehlmann et al., 2015).
Although retrograde menstruation is the oldest and most
widely accepted mechanism, other theories have been proposed
in the pathogenesis of endometriosis. Amongst these, metaplasia
of specialized cells in the peritoneal tissue into endometrial like
cells (Coelomic metaplasia), hormonal imbalance, progesterone
resistance, immune dysfunction and inflammation, are all able to
facilitate lesion growth and a genetic component that provides
bias toward first degree relatives and twins (Sourial et al.,
2014). Understanding the pathogenesis of endometriosis and
how each of these mechanisms may intertwine is an important
area for research. Elucidating risk factors and mechanisms will
enable a more widespread understanding of the development
of endometriosis and ultimately treatment and prevention of
ectopic lesion formation and growth.
Clinical Diagnosis
The most common symptoms of endometriosis include
dysmenorrhea, back pain and chronic lower abdominal pain or
CPP that is associated with bladder filling and defecation. As
these symptoms mimic those of other diseases or conditions,
the clinical diagnosis of endometriosis is complex (Hickey et al.,
2014). Despite multiple studies aimed at identifying biomarkers
in the blood or urine to facilitate non-invasive biological testing
and clinical diagnosis of endometriosis, no biomarkers have
been identified as of yet (Nisenblat et al., 2016; Chapron et al.,
2019). Clinical examination via palpation of the abdominal and
pelvic area, in conjunction with patient history are early stages
of the endometriosis diagnosis process, but are only stepping
stones to further investigation (Riazi et al., 2015). Non-surgical
clinical examination cannot definitively diagnose endometriosis
with ultrasound, the most common non-invasive investigation,
correctly identifying only ∼10% of cases (Pugsley and Ballard,
2007). Recent advances in medical imaging suggests potential for
transvaginal ultrasound and MRI as diagnostic tools for some
types of endometriosis, however, the identification of superficial
peritoneal lesions is not yet possible as the size of the lesions
is below the threshold for detection (Guerriero et al., 2018;
Van den Bosch and Van Schoubroeck, 2018; Chapron et al.,
2019). Accordingly, endometriosis can only be diagnosed and
classified via surgical laparoscopy or laparotomy to confirm the
presence of endometriotic lesions (Hickey et al., 2014). Due
to the surgically invasive nature of this diagnostic testing, as
well as the limited understanding of endometriosis pathology,
progression, and risk factors, there is often frequent misdiagnosis
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FIGURE 1 | Schematic overview of an enhanced immune response leading to chronic pelvic pain in endometriosis. Endometrial fragments in the peritoneum,
originating from the uterus during retrograde menstruation, lead to the production and build-up of iron, reactive oxygen species (ROS), prostaglandins (PGE2) and
acidosis in the peritoneal fluid (peritoneal inflammation). This immune response is also seen at lesions sites throughout the peritoneal cavity, where the increased
production of cytokines, chemokines, growth factors and neutrophils also contribute to an enhanced inflammatory environment present in the peritoneal cavity of
women with endometriosis (lesion inflammation). Of these inflammatory mediators, PGE2, tumor necrosis factor α (TNFα), nerve growth factor (NGF), RANTES and
interleukins (IL) IL-8 and IL-1β are able to directly activate sensory nerve endings and activate a positive feedback loop, further increasing proinflammatory modulator
production (neurogenic inflammation). The enhanced stimulation and activation of peripheral nerve endings in the peritoneal cavity (peripheral sensitization) increases
the painful stimuli transmitted to the spinal cord, initiating and maintaining chronic pelvic pain (central sensitization).
and a consequential delay in determining the correct diagnosis.
Multiple studies investigating the time between the onset of pain
and the diagnosis of endometriosis report a significant delay,
with an average of 8 years in the United Kingdom and up to
12 years in many countries including the United States (Hadfield
et al., 1996; Arruda et al., 2003; Husby et al., 2003; Nnoaham
et al., 2011). Such delays in diagnosis are likely to aid in the
progressive chronicity of the disease.
Once surgically confirmed, the stage and extent of
endometriosis is categorized via a standardized worldwide
classification system into one of four grades, determined
by the severity of lesions/adhesions (Taf, 1979; Canis et al.,
1997). Although this is the standard and accepted method for
classification, there is only a weak correlation between the graded
severity of morphological characteristics and the intensity and
character of pain symptoms (Vercellini et al., 2007; Hsu et al.,
2011). As diagnosis and classification of endometriosis evolves,
it has become clear that it is a chronic and systemic disease with
inadequate understanding, and diagnosed stage is not indicative
of patient suffering (Adamson, 2011; Johnson et al., 2017).
The location of ectopic lesions can vary dramatically between
patients and are found predominantly on the peritoneum, but
also adhered to organs, including ovaries, vagina, fallopian
tubes, bladder, colon and small intestine (Chapron et al., 2003;
Stegmann et al., 2008). Whilst pain is often experienced from the
reproductive organs, pain can also originate from those organs
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in close proximity, such as the bowel and bladder. Accordingly,
patients with endometriosis exhibit significant comorbidity with
chronic abdominal pain and CPP disorders such as interstitial
cystitis/painful bladder syndrome (70–80% of endometriosis
patients) (Chung et al., 2005; Tirlapur et al., 2013) and IBS
(50–70% of endometriosis patients) (Jess et al., 2012; Schomacker
et al., 2018). Although lesions can be removed or ablated as an
initial treatment for endometriosis associated CPP, additional
treatments or further surgery are often required. Whilst surgery,
hormonal and non-hormonal pharmaceutical agents (discussed
in greater detail below) are used to try and resolve CPP (Table 1),




The majority of research into the mechanisms underlying pain
in endometriosis has focused on the endometrial lesions and
adhesions as the primary source of endometriosis-associated
pain. Although lesion specific pain is apparent, and undoubtably
essential for the induction of endometriosis induced pain, lesion
removal does not provide pain relief in all cases, with reports
suggesting 20–28% of patients do not have pain relief following
surgery (Sutton et al., 1994; Abbott et al., 2004). Furthermore,
only a marginal association exists between endometriosis stage
(defined by lesion morphology) and the severity of pelvic
symptoms (Vercellini et al., 2007), suggesting additional complex
mechanisms are involved. More recent understanding of the
mechanisms underlying the development of a chronic pain
state in endometriosis implicates cyclical bleeding from lesions
and subsequent inflammation at both lesion sites and in the
peritoneal cavity. These proinflammatory responses then result
in sensory nerve activation and altered activation of nociceptive
pathways (Table 2) (Morotti et al., 2017; Patel et al., 2018;
Zheng et al., 2019).
Inflammation
In the uterus, the natural breakdown and elimination of
endometrial tissue during menstruation is a highly regulated
response to falling levels of estrogen and progesterone, acting
to remove menstrual debris from the uterus, to make way for
another cycle of endometrial regeneration (Berbic and Fraser,
2013). Carried out by the innate immune system, this process
recruits a large number of immune cells, including neutrophils,
macrophages and natural killer cells (NKs) to facilitate menstrual
breakdown. The endometrial lining undergoes apoptosis and
necrosis and is then finally shed (Berbic and Fraser, 2013). The
programmed cell death during menstruation releases numerous
cellular products, including iron, reactive oxygen species (ROS),
prostaglandins and a family of damage-associated molecular
patterns (DAMPs) amongst others (Laux-Biehlmann et al., 2015).
When retrograde menstruation occurs endometrial fragments
adhere and form lesions within the peritoneum, where they
remain endometrial in nature, expressing estrogen receptors
and undergoing cyclical inflammatory and menstrual events
(Brosens, 1997; Burney and Lathi, 2009). Cyclical bleeding in
response to sex hormones, which naturally occurs in the uterus
during menstruation, can also be seen within the peritoneal
cavity at the site of endometrial lesions (Halme et al., 1984a).
In endometriosis, menstrual by-products also arise from extra-
uterine lesions and are released into the peritoneal cavity
where they initiate immune responses (Table 2 and Figure 1)
(Laux-Biehlmann et al., 2015). Not only does the attempted
breakdown of existing endometriotic lesions and residual
retrograde menstruation in the peritoneal cavity activate an
immune response, but the amplified inflammatory milieu leads
to a build-up of iron, ROS, prostaglandin E2 (PGE2) and acidosis
(Reeh and Steen, 1996). This immune response is evident at
lesion sites, with increased inflammatory cytokines/chemokines,
growth factors, neutrophils and prostaglandins found within
the peritoneal cavity of endometriosis patients (Donnez et al.,
1998; Barcz et al., 2000; Sacco et al., 2012; Králíèková and
Vetvicka, 2015). Of these mediators, PGE2, tumor necrosis factor-
α (TNFα), nerve growth factor (NGF), Regulated on Activation
Normal T cell Expressed and Secreted (RANTES, also known
as C-C chemokine ligand 5: CCL5), and interleukin (IL) IL-
8 and IL-1β are all elevated within the peritoneal fluid of
endometriosis patients who reported CPP pain (Ryan et al.,
1995; Barcz et al., 2000; Bedaiwy et al., 2002; Scholl et al.,
2009). Crucially these mediators are all able to directly activate
sensory nerve endings, suggesting inflammatory mechanisms
may be important in endometriosis associated (Wu et al., 2017;
Liang et al., 2018). A recent study showed that cytokine analysis
of peritoneal fluids could differentiate women diagnosed and
stratified laparoscopically with ovarian endometrioma, peritoneal
endometriosis, or deep infiltrating endometriosis. This suggests
that certain cytokine signatures could be driving different
biological signaling events and immune responses in these
patients (Zhou et al., 2020).
In addition, ROS induce oxidative modification of proteins
and significantly higher levels of protein oxidative stress
markers are found within the peritoneal fluid of women
with endometriosis (Santulli et al., 2015). The targeting of
oxidized proteins with oral antioxidants, including vitamin E
and vitamin C, significantly reduces reported chronic pain
in women with endometriosis compared to placebo following
8 weeks of treatment (Santanam et al., 2013). This treatment
approach also decreased inflammatory markers within the
peritoneal fluid (Santanam et al., 2013). Oxidized proteins, and
the subsequent activation of nociceptors, has been suggested to
promote endometriosis associated pain although the underlying
mechanism remains unclear (Ray et al., 2015; Wright et al., 2017).
Overall, the resulting increase in extra-uterine debris,
heightened by further retrograde menstruation, induces an
enhanced inflammatory response within the peritoneum and
presents an opportunity for the interaction of these immune cells
with sensory nerves to induce CPP (Asante and Taylor, 2011).
Long term exposure to proinflammatory cytokines is proposed
to activate and sensitize sensory nerves present in endometriotic
lesions, initiating the transfer of pain to the central nervous
system (CNS) (Laux-Biehlmann et al., 2015). The activation of
sensory nerve fibers to generate and convey pain to the CNS is
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TABLE 1 | Current approaches for CPP in endometriosis.
Class Type Mechanism Side effects
Hormonal GnRH agonists Aromatase inhibitors
Contraceptive Pill
Modulation of hormone signaling and
prevention of menstruation
Hypoestrogenic – decreased bone density,
mood changes and breast atrophy
Not viable with pregnancy
Non-hormonal NSAIDs Opioids Targets inflammation Often ineffective
Exhibit toxicity
Tolerance, dependence, constipation and
addiction
Surgical Lesion excision or ablation
Partial or complete Hysterectomy
Target lesions or uterus as site of
endometriosis
Invasive surgery with significant complication
rates
Early menopause
Not always viable with pregnancy
(hysterectomy)
TABLE 2 | Pain mechanisms in endometriosis.
Site Mechanism Key players in pain
Inflammation Peritoneal fluid and
endometrial lesions
Retrograde menstruation
and cyclical bleeding at
lesion sites
Activation of an innate immune response increases inflammatory and
nociceptive cytokines/chemokines (TNFα interleukins IL-8 and IL-1β) (Barcz
et al., 2000), ROS, growth factors (NGF and VEGF) (Donnez et al., 1998),




Sensory nerves Build-up of pro-nociceptive
environment can act
directly on sensory nerve
fibers
Degraded tissue by-products including ROS, PGE2 and acidification can
activate sensory nerves (Reeh and Steen, 1996; Holzer, 2011).
Positive feedback loop maintains inflammation by releasing further
proinflammatory modulators including SP and CGRP (Tokushige et al., 2006b).
Peripheral Sensitization Peripheral sensory nerves Neuroplasticity of peripheral
sensory nerves
Persistent inflammation can cause structural and synaptic changes occur to
shift the neuronal function into a more sensitized state (Brierley and Linden,
2014).
The abundance of inflammatory molecules in the peritoneal fluid, including
glycodelin, ROS, TNFα, NGF, and PGE2 may contribute to this (Chiu et al.,
2012).
Central Sensitization Central nervous system
(CNS)
Long term changes in CNS
signaling
Persistent nociceptive barrage leads to a long-lasting central sensitization of
sensory afferents, evoking long term changes in pain processing or ‘memory’







sensitization of the afferents
innervating another organ
Visceral afferents converge into similar areas of the spinal cord providing
opportunity for the sensitization of neighboring cells due to spatial location (Ge
et al., 2019)
a vital step in the pain processing pathway, and contributes to
other forms of chronic visceral pain (Berkley, 2005; Brierley and
Linden, 2014; de Groat et al., 2015; Grundy and Brierley, 2018).
Whilst this cyclical inflammation can exacerbate pain during
menstruation, non-cyclical pain is also experienced by many
women with endometriosis (Vercellini et al., 2007). This suggests
further mechanisms, independent of cyclical events, contribute to
CPP in endometriosis.
Neuroangiogenesis
Pain relies on the existence of sensory transduction pathways
linking peripheral stimuli to the spinal cord for processing
and the brain for perception (Figure 2). However, endometrial
fragments do not have an intrinsic sensory nerve supply
connected to these pathways. For endometrial lesions to induce
chronic pain, the development of new sensory nerves to convey
these signals needs to occur. A number of studies have now shown
that once endometrial fragments adhere to a peritoneal location
and become lesions, they undergo a process of neuroangiogenesis
(Asante and Taylor, 2011). This consists of the coordinated
establishment of a blood supply through the generation of new
blood vessels to support growth and survival (angiogenesis),
together with the synchronized innervation by nerve fibers
(neurogenesis) (Weinstein, 2005).
Neuroangiogenesis is regulated by estrogen and immune
cells, including macrophages, which are an important source of
vascular endothelial growth factor (VEGF) and nerve growth
factor (NGF), both of which are increased in endometriosis
(McAllister et al., 2009; Greaves et al., 2014). Macrophages
exacerbate local inflammation, facilitate growth of ectopic
endometrial lesions and are directly involved in angiogenesis,
releasing chemokines and cytokines that further drive the
growth of endometrial tissue (Hammond et al., 1993; Lin
et al., 2006; Bulun, 2009). In a surgically transplanted
endometriosis mouse model, macrophage secretion of the
angiogenic factors VEGF, TNFα and macrophage inflammatory
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FIGURE 2 | Schematic overview of the sensory innervation of the colon, bladder and uterus/vagina allowing for cross organ sensitization. The colon is innervated by
spinal afferents within the splanchnic and pelvic pathways. These spinal afferents can travel via the splanchnic or pelvic nerves (with some afferents traversing the
hypogastric nerve) and have cell bodies located within the thoracolumbar and lumbosacral dorsal root ganglia (DRG). The bladder is also innervated by both
splanchnic and pelvic pathways (de Groat et al., 2015). The central terminals of colon and bladder afferents terminate within the dorsal horn of the thoracolumbar
and lumbosacral dorsal horn (Harrington et al., 2012, 2019; Grundy et al., 2018). Afferents innervating the uterus and vagina also share the splanchnic and pelvic
pathways, whilst the vagina is also innervated by the pudendal nerves, with cell bodies within the lumbosacral DRG and central terminals within the lumbosacral
dorsal horn (Berkley, 2005). The central terminals of colon, bladder, uterus and vaginal afferents synapse onto second order dorsal horn neurons in the spinal cord,
which ultimately transmit signals to the brain. Accordingly, these different visceral organs share common nerve pathways to the DRG and spinal cord, allowing the
potential for cross-organ sensitization. TL, Thoracolumbar; LS, Lumbosacral; IMG, Inferior Mesenteric Ganglion; MPG, Major Pelvic Ganglion.
proteins (MIP-1α and MIP-2) into the peritoneal fluid in
early stages of endometriosis progression correlated with
a peak in active angiogenesis in lesions (Lin et al., 2006).
Heightened angiogenesis, driving both the establishment
and growth of endometrial lesions, is also evident in
patients. Studies have identified increased angiogenic factors,
including VEGF and TNFα, in the pelvic peritoneal fluid
of patients with endometriosis (Shifren et al., 1996). These
changes are further supported by a rich vascularization
correlating with more active peritoneal endometrial lesions
(Nisolle et al., 1993).
As angiogenic factors promote blood supply and support
lesion growth and establishment, neurotrophic factors are
essential for the development of both autonomic neurons
and sensory afferent neurons, of which the latter can
transmit nociceptive stimuli (Yan et al., 2017; Skaper, 2018).
An increased density of small, unmyelinated nerve fibers
(sensory afferents, sympathetic, and parasympathetic efferents)
have been found in endometrial lesions (Tokushige et al.,
2006b) and the endometrium of women with endometriosis
(Tokushige et al., 2006a). The vast majority of these
unmyelinated nerve fibers have been identified as C-fiber
sensory afferents, unmyelinated nerves that typically function
as nociceptors, implicating them strongly in the generation of
CPP in endometriosis (Wang et al., 2009a). Directly highlighting
their importance in CPP, early removal of lesions, before they
established nerve fiber innervation, reversed hypersensitivity
seen in an endometrial mouse model (McAllister et al.,
2012). Moreover, endometriosis-associated menstrual pain
was highest in women whose endometriotic lesions had
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increased nerve fiber innervation (Mechsner et al., 2009;
McKinnon et al., 2012).
An increase in neuroangiogenic markers has been linked
to a dense nerve supply in lesions and is closely related
to CPP symptoms in women suffering from endometriosis
(Kajitani et al., 2013; Morotti et al., 2014). Markers for both
adrenergic and cholinergic neurons (neuropeptide Y), as well as
unmyelinated C-fibers (substance P: SP, calcitonin gene-related
peptide: CGRP) are significantly higher in the endometrium
of patients with endometriosis (Kajitani et al., 2013). Increased
levels of neurotrophins and their receptors, including NGF
and its receptor tyrosine kinase A (TrkA), are also seen in
endometrial biopsies of women with endometriosis (Tokushige
et al., 2008). NGF promotes new nerve sprouting and acts directly
on existing sensory nerve fibers to induce pain (Anaf et al.,
2002; Chao, 2003). These effects are exacerbated by increased
levels of circulating estrogen in women with endometriosis, as
estrogen can enhance NGF activation of TrkA (Bjorling et al.,
2002). This is important as its downstream target is the well-
known nociceptive cation channel transient receptor potential
subfamily V member 1 (TRPV1), which has been found to be
upregulated in endometriomas and ectopic endometrial cells
(Wang, 2008; Bohonyi et al., 2017). An increase in the density of
nerve endings throughout lesions and an enhanced excitability of
nerves provides the basis for increased nociception at lesion sites.
The nerve injury-induced protein 1 (Ninj1), which promotes
neurite outgrowth, has also been found to be expressed in ovarian
and peritoneal endometriotic tissues (Miyashita et al., 2019).
Together with the establishment and growth of endometrial
lesions, neuroangiogenesis aids irritation and invasion of
existing nerves. Nerve density is increased in deep infiltrating
endometriotic nodules when compared to healthy vaginal tissue,
an observation also seen in peritoneal endometriotic lesions
relative to the normal peritoneum (Tokushige et al., 2006b;
Wang et al., 2009b; Anaf et al., 2011). The close proximity of
endometrial adhesions and lesions to pelvic nerves can cause
their encapsulation or compression, which contributes to CPP
associated with endometriosis (Tulandi et al., 2001). Hyperalgesia
due to dense nerve supply and encapsulation is supported
by multiple studies, which show the highest pain score from
endometriosis patients correlates with a higher density of nerves
and nerve encapsulations (Anaf et al., 2000; Mechsner et al., 2009;
McKinnon et al., 2012).
It has also been suggested that an imbalance between the
activation of anti-nociceptive and pro-nociceptive ion channels
on these lesion innervating neurons is a possible mechanism
for pain pathophysiology (Arnold et al., 2012). Such imbalances
also contribute to other visceral pain conditions (Sadeghi et al.,
2018). An imbalance resulting in increased nociceptive input,
with a decreased parasympathetic control at lesion sites could
lead to a heightened pain response. Changes in this autonomic
equilibrium occur in a number of chronic visceral pain disorders
including fibromyalgia, gastroesophageal reflux disease and IBS
(Aziz, 2013), with decreased parasympathetic and increased
sympathetic activity (Heitkemper et al., 1998), favoring the
transmission of painful stimuli. Sensory nerves had a significantly
higher density in areas close to endometriotic lesions compared
to sympathetic nerve fibers (Arnold et al., 2012). Interestingly,
it has been shown that traditional hormone therapies that
alleviate pain in endometriosis, including progestogens and
oral contraceptives, significantly reduced nerve fiber density
in ectopic endometrium (Tokushige et al., 2008). Although
a novel finding, pain severity was not assessed, and further
studies are needed to determine if the nerve fiber reduction
in endometrial lesions in response to hormone therapy would
show a clinical effect on lesion specific pain. Along these
lines, estrogen receptor expression in endometrial samples has
been shown to predict symptom severity and pain recurrence
in endometriosis. In particular a higher expression of ER-α
increased the prospect of moderate to severe dysmenorrhea
and deep dyspareunia. Correspondingly, progestin therapy
reduced ER-α expression, whereas androgen receptor, aromatase
expression and progesterone receptor abundance were unaltered
(Pluchino et al., 2020).
Neurogenic Inflammation
Adding to the already pro-nociceptive environment induced by
endometrial lesions in the peritoneal cavity, build-up of degraded
tissue by-products, including ROS, PGE2 and acidification can
directly act on or sensitize sensory nerve fibers through receptors
on nociceptive afferent nerves located within lesions (Table 2 and
Figure 1) (Reeh and Steen, 1996; Ma and Quirion, 2008; Holzer,
2011). Compounding this nociceptive barrage, sensitized sensory
nerve fibers maintain inflammation by a positive feedback loop
called ‘neurogenic inflammation.’ Excitation of these nerve fibers
results in their terminals releasing further pro-inflammatory
modulators. This includes neuropeptides such as SP and CGRP,
both of which are found close to endometrial lesions in
women with endometriosis associated pain (Tokushige et al.,
2006a). Moreover, activation of sensory afferent nerves initiates
the recruitment of mast cells and subsequent release of pro-
inflammatory cytokines, including TNFα, NGF, PGE2 and a
variety of interleukins, such as IL-1β, which contributes to a
chronic state of neurogenic inflammation (van der Kleij et al.,
2009; Chiu et al., 2012). This inflammation encourages further
stimulation of locally circulating mast cells and macrophages
that are found in elevated levels and in close proximity to
nerve fibers in women with endometriosis (Bacci et al., 2009).
A number of other chronic pain conditions, such as asthma,
arthritis, interstitial cystitis, IBS, Inflammatory Bowel Disease
(IBD; including Ulcerative Colitis and Crohn’s Disease), show a
chronic neurogenic inflammatory state that induces chronic pain
(Bordman and Jackson, 2006; van der Kleij et al., 2009; Brierley
and Linden, 2014; Straub and Schradin, 2016).
Peripheral Sensitization
Neuroplasticity of peripheral sensory nerves, such that structural,
synaptic or intrinsic changes occur to shift neuronal function
into a more sensitized state, is an established process in the
development of chronic visceral pain (Brierley and Linden,
2014; Grundy et al., 2019). Under normal circumstances,
peripheral sensitization causes the threshold for neuronal
activation to drop, inducing pain from a stimulus that does not
normally provoke pain (allodynia) or heightens existing pain
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(hyperalgesia). This mechanism provides protection from further
damage following the development of inflammation from an
existing injury (Iyengar et al., 2017). However, if inflammation
persists, or a maladaptation to the original sensitizing stimuli
occurs, nociceptors can become chronically hypersensitive even
after inflammation resolves and histology appears normal.
This peripheral hypersensitivity of nociceptive fibers at lesion
sites may play a role in allodynia and hyperalgesia seen in
endometriosis patients (Figure 1) (Morotti et al., 2017).
As described above, there is an abundance of inflammatory
molecules, including glycodelin, ROS, TNFα, NGF and PGE2
in the peritoneal fluid of women with endometriosis, which
may contribute to the induction of a more pro-nociceptive
state (Table 2) (Chiu et al., 2012; St-Jacques and Ma, 2014).
Increased levels of TNFα and glycodelin correlate with central
hyperexcitability in response to repeated electrical stimulation
and altered pain response to nociceptive withdrawal reflex, as well
as higher levels of menstrual pain experienced by endometriosis
patients (Scholl et al., 2009; Neziri et al., 2014). Patients with the
highest pain scores also had the highest levels of TNFα, which
was independent of lesion score (Overton et al., 1996). Further
supporting a role in chronic pain conditions, TNFα activates
nerve fibers innervating the colon, and has been shown to be
elevated in samples from IBS patients, which correlates with
patient clinical pain scores (Hughes et al., 2013).
The nociceptive ion channel TRPV1 has been implicated in
other chronic pain conditions such as rheumatoid arthritis, osteo
arthritis and IBS (Wang, 2008; Basbaum et al., 2009; Sadeghi
et al., 2018), acting as a molecular sensor to potentiate and
integrate responses to pain inducing stimuli, such as acidosis,
oxidative stress or inflammatory mediators (Tominaga and Julius,
2000; Wang, 2008). Supporting an involvement of TRPV1 in
endometriosis associated pain, elevated expression of TRPV1
has been found in dorsal root ganglion (DRG) of rats with
endometriosis (Lian et al., 2017) as well as locally on infiltrating
adhesions in endometriosis patients, the increase correlating with
pain intensity (Rocha et al., 2011; Bohonyi et al., 2017). This is not
surprising, as a number of the processes responsible for TRPV1
upregulation and sensitization are found in endometriosis
patients, including enhanced ROS concentrations and increased
levels of neurotrophins such as NGF. Together these mechanisms
have the ability to activate TRPV1 as well as increase its
expression, further driving sensitization of peripheral nociceptors
(Wang, 2008; Ma et al., 2009; Kajihara et al., 2011). It has been
proposed that chronic sensitization of peripheral sensory nerve
fibers in turn induces sensitization of the CNS in endometriosis
(Berkley et al., 2005; Arnold et al., 2012). Recent studies also
show exposure to chronic stress early in life can increase the
likelihood of CPP later in life, whilst bouts of acute stress can
trigger or worsen symptoms (Pierce et al., 2014, 2015; Pierce and
Christianson, 2015; Fuentes and Christianson, 2018).
Central Sensitization
Chronic hyperexcitability of peripheral afferents has also been
shown to induce long-term changes in CNS signaling, as
well as increased sprouting of central terminals within the
spinal cord dorsal horn in other painful visceral disorders,
including IBS and interstitial cystitis (Harrington et al., 2012;
Grundy et al., 2018, 2019). These conditions contribute to the
sensitization of neurons in the CNS that produces long lasting
hyperexcitability in the absence of noxious stimuli (Anaf et al.,
2006; Schulke et al., 2009). The persistent nociceptive barrage
from inflammatory endometriotic lesions is thought to lead to a
long lasting central sensitization of sensory afferents (Figure 1)
(Bajaj et al., 2003). This phenomenon has been seen in patients
with chronic pain related to osteoarthritis, whiplash (Koelbaek
Johansen et al., 1999) and fibromyalgia (Harris et al., 2009)
and is often considered the cause for ‘unexplained’ chronic pain
(Nijs et al., 2011).
Central sensitization can evoke long-term changes in pain
processing, similar to the generation of ‘memory.’ Neonatal
irritation of hollow organs or maternal separation are able to
drive long-term visceral/somatic hypersensitivity and central
sensitization (Pierce et al., 2014, 2015; Fuentes and Christianson,
2018). Central sensitization is also often initiated and maintained
by peripheral sensitization, resulting in pain persisting long after
the peripheral insult or pathology or has resolved (Table 2)
(Woolf, 2011). This may be particularly relevant in endometriosis
as many women experience persistent pain despite treatment or
removal of endometrial lesions (Shakiba et al., 2008; Li et al.,
2018). Furthermore, women with dysmenorrhea (menstrual
pain) have increased CNS activation to noxious stimuli compared
to women who don’t experience menstrual pain, a phenomenon
seen at various stages of the menstrual cycle (Vincent et al.,
2011). Accordingly, central sensitization of pain pathways could
help to explain why chronic pain persists in some patients
following lesion removal or why diagnosed lesion scores don’t
correlate with pain intensity (Li et al., 2018). With this in
mind, the location of the lesions, and their proximity to major
peripheral nerves may provide an important but overlooked
contribution to the development of chronic pain in patients
diagnosed with endometriosis.
Neuroimaging has been used to identify chronic changes in the
brains of women with CPP, both with and without endometriosis.
A decreased volume of gray matter has been identified in areas
of the brain related to pain processing, including the thalamus
and insula, a brain region consistently activated during acute and
chronic pain states (As-Sanie et al., 2016). These changes were
seen in women with endometriosis that experience CPP but not
in asymptomatic women, further supporting a role for CNS pain
processing in CPP. Furthermore, proton magnetic resonance
spectroscopy determined that women with endometriosis had
increased levels of excitatory neurotransmitters in their anterior
insula compared with healthy women (As-Sanie et al., 2016).
Using an animal model of endometriosis, changes in gene
expression in similar pain processing areas of the brain, including
the amygdala, insula and hippocampus were also observed
(Li et al., 2018).
Not only does central sensitization alter the pain response
from the area of insult, it can also alter pain from seemingly
unrelated areas. Animal models of endometriosis experience
allodynia and hyperalgesia to different noxious stimuli including
heat and vaginal distension (Nagabukuro and Berkley, 2007;
McAllister et al., 2009; Li et al., 2018). Similarly, a cohort of
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endometriosis patients experienced enhanced muscular pain
following saline injection into the hand when compared to
healthy participants (Bajaj et al., 2003). In these scenarios,
both hyperalgesia and allodynia are apparent once a stimulus
is applied, allowing the changes in sensitization to become
apparent. Although increased pain responses have been
demonstrated in both animal and human studies, the CNS
pathway changes, together with the molecular mechanisms
underlying central sensitization in endometriosis, are more
difficult to determine.
Although changes in central pain processing have been
reported in endometriosis, whether they exacerbate CPP
following changes initiated by endometriosis, or whether these
women are already sensitized and have a heightened response to
endometrial disease, is unclear. As the delay between onset of
pain and diagnosis and treatment of endometriosis is typically
between eight to 12 years, there is ample opportunity for
these lesions to induce the chronic changes needed to induce
central sensitization. Although it is currently unknown if earlier
diagnosis and removal of lesions could reverse or avoid these
changes in patients, the removal of lesions in the early stages
of progression in animal models reversed the pain experienced
(McAllister et al., 2009, 2012), whilst removing them at later
stages had no effect (McAllister et al., 2012).
Cross-Organ Sensitization
Women with endometriosis have a high comorbidity rate with
other chronic pain syndromes associated with peripheral and
central changes in pain processing, including, fibromyalgia,
migraine headaches, IBS and painful bladder syndrome (Chung
et al., 2002). The phenomenon of cross-organ sensitization,
described as the spreading of noxious inputs from a diseased
visceral organ to a normal organ in close proximity, has been
studied in other pathological conditions where comorbidities
are common, including IBS, IBD, interstitial cystitis and other
CPP disorders (Wesselmann, 2001; Winnard et al., 2004, 2006;
Pezzone et al., 2005; Grundy and Brierley, 2018).
Experimental evidence of functional cross-organ sensitization
in the pelvis has been observed in many combinations,
including bladder/colon (Qin et al., 2005; Grundy et al., 2018),
vagina/colon, bladder/uterus (Ge et al., 2019) and uterus/colon
(Lamb et al., 2006; Winnard et al., 2006). For example,
uterine inflammation produced signs of inflammation in the
colon and the bladder (Winnard et al., 2004), whilst bladder
inflammation has been found to alter uterine contractility
(Dmitrieva et al., 2001). These alterations have been displayed
in preclinical endometriosis models where abnormal endometrial
tissue growth induced vaginal hyperalgesia in a rat, which was
exacerbated by estradiol (Berkley et al., 2007; Nagabukuro and
Berkley, 2007). It has also been demonstrated that endometriosis
increased pain behaviors of rats with kidney stones, another
comorbidity of women with endometriosis (Giamberardino et al.,
2002), and reduced the micturition threshold of rats, indicating
increased urinary urgency and frequency, a clinical symptom of
bladder disorders (Chung et al., 2002; Berkley, 2005).
Cross-organ sensitization is thought to occur when sensitized
afferents from one organ induce sensitization of the afferents
innervating another organ (Table 2 and Figure 2). Visceral
afferents converge into similar areas of the spinal cord providing
opportunity for the sensitization of neighboring cells due to
spatial location (Grundy et al., 2018; Ge et al., 2019). The
precise mechanisms responsible for cross-organ sensitization
are unclear, however, overlap of peripheral afferent pathways
within the DRG and spinal cord are crucial (Aredo et al., 2017;
Grundy and Brierley, 2018; Grundy et al., 2019). Following
neuroangiogenesis, which includes the presence of CGRP,
TRPV1, and TRPA1 expressing nerve fibers (Fattori et al.,
2020), the sensory nerves innervating endometriotic lesions may
converge into the same spinal pathways from the afferents they
originally sprouted from in the periphery. As such, they will
share the same cell bodies in the DRG and the same central
terminals within the spinal cord (Costa et al., 2004). As the
location of ectopic lesions appears to be random, this could help
to explain why the experience of pain is heterogenous within an
endometriosis population.
With retrograde menstruation the primary theory for
development of endometriosis, pelvic lesions are often found
around the reproductive tract, with extra-pelvic lesions found
in close proximity, located frequently upon the gastrointestinal
tract and urinary system (Matalliotakis et al., 2017). Pain from
these more distant lesions often mimics the pain from pelvic
lesions and the extent of disease continues to be independent
from symptom severity, regardless of lesion location. Conscious
pain mapping of women with endometriosis confirmed half of
participants localized their pain to lesion sites, but many women
described generalized pain in the pelvis and bowel, indicating
a widespread visceral hypersensitivity and pain independent of
lesion location (Howard et al., 2000; Hsu et al., 2011). Palpation
of various lesion types during laparoscopy of women with
endometriosis also saw pain extend into normal looking tissue
(Demco, 1998), whilst referred pain was reported in half of
women under conscious sedation during laparoscopy for CPP
(Demco, 2000). Lesion specific pain on visceral organs may
be explained by neuroangiogenesis in lesions converging with
existing neuronal pathways in the adhered organ, promoting
cross-organ sensitization due to shared nerve pathways.
Cross-organ sensitization may also occur through shared
innervation pathways of anatomically distinct organs. Recent
studies have shown that a single peripheral neuronal cell body
located within the DRG is able to generate multiple axons
that innervate a number of abdominal organs simultaneously
(Christianson et al., 2007; Chaban, 2008; Jobling et al., 2010).
Often referred to as ‘dichotomizing afferents,’ these nerve
fibers converge from multiple visceral organs to a single cell
body within the DRG and therefore terminate onto the same
second order spinal neurons. Whilst the evolution of these
dichotomizing afferents is embedded within the physiological
coordination of sexual, defecatory and urinary function,
sensitization of these pathways in pathological conditions can
allow cross-organ sensitization to occur. Retrograde tracing has
revealed these neurons co-innervate a number of pelvic organs
including the colon/bladder (Christianson et al., 2007; Grundy
et al., 2018), colon/vagina (Ge et al., 2019), and colon/uterus
(Chaban, 2008; Broad et al., 2009).
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The chronic generalized hypersensitivity across visceral
organs may in part be a result of cross-organ sensitization. The
female reproductive tract is innervated by splanchnic, pelvic
and pudendal nerve pathways, presenting an opportunity for
cross talk through shared neuronal pathways of other organs
in close proximity, such as the bladder and bowel. Whilst
nerve development within lesions has been of interest, further
understanding the path that new nerves take and the changes they
facilitate is a necessary step in interpreting pain progression in
endometriosis patients.
CURRENT TREATMENTS
Eighty percent of endometriosis patients suffer from CPP,
with subfertility affecting 60% of these women. Although both
symptoms are prevalent, their treatment is often independent,
with reproductive plans complicating optimal treatment
regimens. With up to 87% of women presenting with CPP found
to have endometriosis (Falcone and Flyckt, 2018), the treatment
of CPP is an effective strategy to improve the quality of life
in these patients, independent of subfertility. Overall, current
therapeutic options provide pain relief for more than 6 months
in only 40–70% of patients (Howard, 2000; Guo, 2009). As
such, a greater understanding of the mechanisms underlying
endometriosis induced pain is necessary to achieve greater
clinical outcomes in the future.
As briefly mentioned above, traditional treatments focus
on lesions as the cause of CPP associated with endometriosis
(Table 2). Modulation of hormonal signaling via gonadotropin-
releasing hormone (GnRH) agonists, aromatase inhibitors and
oral contraceptive pills is known to suppress pain symptoms via
estrogen inhibition and prevention of menstruation. However
their incompatibility with fertility make them a short term
treatment option for many women, with conclusion of treatment
seeing the return of menstruation and symptoms (Kitawaki et al.,
2002; Guo, 2009; Slopien and Meczekalski, 2016). By reducing
the availability of estrogen, the estrogen dependent disease
is significantly diminished, and cyclical bleeding is abolished.
Although initially effective, pain relief was noted in only 40–
70% of patients after 6 months (Howard, 2000). Together with
the hypoestrogenic side effects including loss of bone mineral
density and secondary osteoporosis, mood changes and breast
atrophy (Kim et al., 2011), the use of GnRH is approved for
only 6 months. Furthermore, contraceptive pills are not viable
with pregnancy, making them a short-term solution for many
women, especially those with reproductive plans. Aromatase
inhibitors inhibit extra-ovarian estrogen production, making
them particularly relevant for post-menopausal women or in
combination with GnRH agonists, however, their reduction in
pain is again offset by adverse side effects, including osteoporosis
and bone fractures (Slopien and Meczekalski, 2016).
Non-hormonal pain reducing agents such as non-steroidal
anti-inflammatory drugs (NSAIDs) and strong analgesics
(opioids) reduce inflammation and mask pain (Brown
et al., 2017). NSAIDs are used to target inflammation,
although a review of their effectiveness in managing pain
caused by endometriosis is inconclusive (Brown et al., 2017).
Unfortunately, it has also been noted that NSAIDs are often
ineffective and exhibit toxicity (Allen et al., 2005). Opioids
therapy is also used to treat chronic pain associated with
endometriosis and surgical intervention (Lamvu et al., 2019).
Whilst opioids provide pain management, their effectiveness in
the treatment of endometriosis is not reliably understood. Misuse
and abuse is a growing problem amongst many chronic pain
conditions, together with tolerance and addiction making opioids
an undesirable treatment option (Kanouse and Compton, 2015).
Unfortunately, whilst these medications represent a relatively
non-invasive treatment plan, they either lack efficacy, or result in
tolerance, dependence and addiction.
As the most invasive option, but often required due to the
debilitating nature of chronic pain (Kanouse and Compton,
2015) and treatment of endometriosis associated subfertility,
surgical treatment of endometriosis is based on the principal
of removing all endometriotic lesions to alleviate symptoms.
Whilst endometrial lesions within the peritoneum can be excised
or ablated, they often grow back due to continuing retrograde
menstruation and disease progression, and further surgery is
needed in many cases (Cheong et al., 2008). Between 20–28%
of patients are non-responsive to surgery (Sutton et al., 1994;
Abbott et al., 2004), whilst reoccurrence is as high as 40–50% at
5 years post-surgery (Shakiba et al., 2008). The surgical removal of
lesions can sometimes prove challenging depending on the stage
and grade of endometriosis, which further complicates outcomes.
Surgical removal of deep infiltrating endometrial lesions reduces
endometrial CPP, but is associated with significant complication
rates, requiring complex surgery to remove lesions, with resection
of the bowel, damage to the bladder wall and stenting of the
ureter often required (Wee-Stekly et al., 2015). The lowest rates
of further surgery in pain management is following complete
hysterectomy, with over 90% of patients remaining follow-up
surgery free for up to 7 years, although the removal of the
ovaries as well as the uterus is not as effective in younger
women (Shakiba et al., 2008). In addition, associated health risks
due to early menopause and incompatibility with pregnancy
make hysterectomy a non-viable treatment for many women of
reproductive age (Shakiba et al., 2008).
Even with a combination of therapies, complete eradication
of endometrial associated pain is rarely possible. While the
current therapies aim to suppress pain and delay reoccurrence,
the disease often manifests itself once treatments have stopped or
lesions have reformed. While the complete eradication of lesions
is not likely, further understanding of chronic pain associated
with endometriosis and identification of possible targets for pain
management may help improve the quality of life for those
suffering with endometriosis.
Future Therapies? Insights From Animal
Models of Endometriosis
Endometriosis is currently considered an inflammatory disease,
with non-surgical treatment targeted at the prevention of
menstruation and hormonal therapy to limit disease progression
and inflammation. It is increasingly evident that this disease has
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a multifaceted nature with 40% of women experiencing non-
cyclical pelvic pain, thus limiting endometriosis treatment to
anti-inflammatory or hormonal control of menstruation seems to
miss the mark. Currently the delay in diagnosis allows complex
disease progression, increasing the opportunity for long term
changes in pain processing to occur. Although progress has
been made in the diagnosis and classification of endometriosis,
assistance in early diagnosis is still of importance. Recent research
priorities for endometriosis include an emphasis on biomarkers
and imaging for non-invasive diagnostic techniques (Rogers
et al., 2017). Despite multiple studies aimed at identifying a
reliable biomarker as a clinical diagnostic tool, a systematic
review of the last 25 years concluded that no single biomarker
was confirmed to be clinically useful (May et al., 2010).
Strikingly, it has also been noted that very little progress
has been made in understanding chronic pain associated with
endometriosis, and subsequent advancement in treatment is
lacking (Rogers et al., 2017).
Modulating pain at an ion channel level and the targeting
of specific pain receptors at lesion sites or organs involved in
cross-organ sensitization may provide a novel and non-hormonal
approach for endometriosis patients suffering from CPP (Castro
et al., 2020). Indeed, limiting neuroangiogenesis to prevent lesion
innervation and growth, together with direct modulation of key
targets on peripheral nerves, is an important direction for future
CPP management in endometriosis. Supported by evidence from
a mouse model of endometriosis, lesion removal at early time
points reduces CPP (McAllister et al., 2009, 2012; McKinnon
et al., 2012). But in many cases this approach is not possible,
whether it be delayed diagnosis, incomplete lesion removal, or
deep infiltrating lesions, it is clear complete lesion removal at an
early time point is a difficult venture.
Animal models of endometriosis have demonstrated
novel mechanisms for reducing CPP. This includes the use
of estrogen EP2 receptor antagonists to reduce primary
hyperalgesia by 80% and secondary hyperalgesia by 40%
in a mouse model of endometriosis (Greaves et al., 2014).
Furthermore, bradykinin receptor 2 antagonists can block
bradykinin induced endothelin-1 production, which is important
as endothelin-1 causes neuronal sensitization (Yoshino
et al., 2018). Other studies have demonstrated a key role
for GPR30, a G protein-coupled receptor for estrogen, in
endometriosis associated pain, whereby intra-lesion GPR30
agonists produce persistent mechanical hyperalgesia, whilst
GPR30 antagonists inhibit mechanical hyperalgesia (Alvarez
et al., 2014). Conversely, activation of cannabinoid receptor
type 1 (CB1R), which are expressed by the sensory and
sympathetic neurons innervating endometrial lesions, decreases
endometriosis-associated hyperalgesia (Dmitrieva et al., 2010).
Moreover, antagonists of CB1R increase endometriosis-
associated hyperalgesia, suggesting an endogenous cannabinoid
tone (Dmitrieva et al., 2010). More recent studies show
that 19-tetrahydrocannabinol (THC) alleviates mechanical
hypersensitivity and pain in a mouse model of surgically
induced endometriosis. THC also restored cognitive function
and inhibited the development of endometrial cysts (Escudero-
Lara et al., 2020). These studies suggest CB1R plays a
crucial role in the growth of lesions and endometriosis
associated pain.
Recent studies have also suggested the potential of
repurposing treatments for other conditions. This includes
repurposing dichloroacetate, a pyruvate dehydrogenase kinase
(PDK) inhibitor/PDH activator used for treating cancer.
This is because dichloroacetate normalizes human peritoneal
mesothelial cells metabolism, reduces lactate concentrations
and endometrial stromal cell proliferation in a co-culture cell
model. In a mouse model of endometriosis oral administration of
dichloroacetate reduces lactate concentrations within peritoneal
fluid and endometrial lesion size (Horne et al., 2019).
Animal models of other chronic pain conditions, such as
IBS, have been used to successfully demonstrate the modulation
of pain by targeting the periphery. For example chronic
treatment with a guanylate cyclase-C (GC-C) agonist reversed
the neuroplastic changes that cause both colonic hypersensitivity
and cross-organ sensitization of the bladder in a mouse model of
IBS (Grundy et al., 2018). More recently, the same agonist, whose
direct target GC-C is expressed within the gastrointestinal tract,
has been used to reduce vaginal hyperalgesia and allodynia in a rat
model of endometriosis (Ge et al., 2019). This gives rise to the idea
that targeting pain in one area may in fact reduce pain from other
organs and that chronic changes due to an area of insult in one
organ may in fact modulate pain experienced in another. Using
animal models of endometriosis provides an important medium
to explore the use of existing drugs for the treatment of pain
associated with endometriosis and should continue to be utilized.
This review provides evidence for an overall heterogeneity
in endometriosis, rather than a ‘one size fits all’ approach. This
strongly suggests a personalized treatment approach based on
etiology and symptomatology. Shifting the paradigm of lesion
specific and cyclical inflammatory pain will continue to open up
further areas to expand treatment opportunities. Utilizing animal
models of endometriosis that closely recapitulate the human
disease will provide an insightful opportunity to further study
disease progression and chronic pain. With the development of
animal models of endometriosis already providing quality insight
into disease progression and current treatment mechanisms,
the next step is to dig a little deeper, and elucidate disease
specific changes and their targets at the lesion, DRG, spinal cord
and brain levels.
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